Zobrazeno 1 - 10
of 263
pro vyhledávání: '"Mei Hsuan Lee"'
Autor:
Ming‐Lun Yeh, Chia‐Yen Dai, Chung‐Feng Huang, Shiu‐Feng Huang, Pei‐Chien Tsai, Po‐Yau Hsu, Ching‐I Huang, Yu‐Ju Wei, Po‐Cheng Liang, Ming‐Jong Bair, Mei‐Hsuan Lee, Zu‐Yau Lin, Jee‐Fu Huang, Ming‐Lung Yu, Wan‐Long Chuang
Publikováno v:
Kaohsiung Journal of Medical Sciences, Vol 40, Iss 6, Pp 575-582 (2024)
Abstract Lifestyle modification is the standard of care for nonalcoholic fatty liver disease (NAFLD) patients. We aimed to investigate the efficacy of a short‐term lifestyle modification program in the disease course of Taiwanese nonalcoholic steat
Externí odkaz:
https://doaj.org/article/9836ab2271004d25a026d0f6ddf8f8fa
Autor:
Chia‐Yu Kuo, Ming‐Ju Tsai, Jen‐Yu Hung, Mei‐Hsuan Lee, Kuan‐Li Wu, Yu‐Chen Tsai, Cheng‐Hao Chuang, Chung‐Wen Huang, Chin‐Ling Chen, Chih‐Jen Yang, Inn‐Wen Chong
Publikováno v:
Kaohsiung Journal of Medical Sciences, Vol 40, Iss 5, Pp 467-476 (2024)
Abstract Combining epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) with an anti‐ vascular endothelial growth factor (VEGF) agent, bevacizumab or ramucirumab, is indicated for advanced lung adenocarcinoma harboring EGFR mutat
Externí odkaz:
https://doaj.org/article/ccc67b4d159f480788789dc5c0166cb1
Autor:
Chun-Chi Yang, Chung-Feng Huang, Te-Sheng Chang, Ching-Chu Lo, Chao-Hung Hung, Chien-Wei Huang, Lee-Won Chong, Pin-Nan Cheng, Ming-Lun Yeh, Cheng-Yuan Peng, Chien-Yu Cheng, Jee-Fu Huang, Ming-Jong Bair, Chih-Lang Lin, Chi-Chieh Yang, Szu-Jen Wang, Tsai-Yuan Hsieh, Tzong-Hsi Lee, Pei-Lun Lee, Wen-Chih Wu, Chih-Lin Lin, Wei-Wen Su, Sheng-Shun Yang, Chia-Chi Wang, Jui-Ting Hu, Lein-Ray Mo, Chun-Ting Chen, Yi-Hsiang Huang, Chun-Chao Chang, Chia-Sheng Huang, Guei-Ying Chen, Chien-Neng Kao, Chi-Ming Tai, Chun-Jen Liu, Mei-Hsuan Lee, Hsing-Tao Kuo, Pei-Chien Tsai, Chia-Yen Dai, Jia-Horng Kao, Han-Chieh Lin, Wang-Long Chuang, Kuo-Chih Tseng, Chi-Yi Chen, Ming-Lung Yu
Publikováno v:
Infectious Diseases and Therapy, Vol 13, Iss 6, Pp 1199-1213 (2024)
Abstract Introduction Eight-week glecaprevir/pibrentasvir (GLE/PIB) is indicated for treatment-naïve (TN) patients with chronic hepatitis C (CHC), with or without compensated cirrhosis. Given that the Taiwanese government is committed to eliminating
Externí odkaz:
https://doaj.org/article/14215fa1ee784d7ab2393d1356d5db36
Autor:
Huang-Chi Chen, Chia-Yu Kuo, Yu Chang, Dong-Lin Tsai, Mei-Hsuan Lee, Jui-Ying Lee, Hui-Ming Lee, Yu-Chieh Su
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-12 (2024)
Abstract Background Lung cancer is a leading cause of cancer-related mortality worldwide, and effective therapies are limited. Lung cancer is a leading cause of cancer-related mortality worldwide with limited effective therapy. Sorafenib is a multi-t
Externí odkaz:
https://doaj.org/article/ade39340661f4f82849a085c6ce84a3b
Autor:
Ming-Lung Yu, Chih-Yuan Wang, Mei-Hsuan Lee, Horng-Yih Ou, Pin-Nan Cheng, Shih-Te Tu, Jee-Fu Huang, Jung-Fu Chen, Tsung-Hui Hu, Chih-Cheng Hsu, Jia-Horng Kao, Chien-Jen Chen, Han-Chieh Lin, Chien-Ning Huang
Publikováno v:
Journal of the Formosan Medical Association, Vol 122, Iss 3, Pp 202-220 (2023)
Diabetes mellitus (DM) and hepatitis C virus (HCV) infection are prevalent diseases globally and emerging evidence demonstrates the bidirectional association between the two diseases. Direct-acting antivirals (DAAs) for HCV have a high treatment succ
Externí odkaz:
https://doaj.org/article/76ce0970d9254ce69a1cfee221491b1c
Autor:
Szu-Ling Chang, Chih-Hung Lai, Guan-Cheng Lin, Yi-Ming Chen, Mei-Hsuan Lee, Han-Shui Hsu, I-Chieh Chen
Publikováno v:
Biomedicines, Vol 11, Iss 12, p 3273 (2023)
Background: Human leukocyte antigen (HLA) genes are important in many immune processes and contribute to many adverse drug reactions. Whether genetic variations in the HLA region are associated with non-steroid anti-inflammatory drug (NSAID) hypersen
Externí odkaz:
https://doaj.org/article/9889d4ce90164f86bfccfaeab79508fd
Autor:
En‐Chi Hsu, Kuan‐Li Wu, Ying‐Ming Tsai, Mei‐Hsuan Lee, Ming‐Ju Tsai, Chia‐Yu Kuo, Yu‐Chuan Liu, Fu‐Wen Liang, Chih‐Jen Yang, Jen‐Yu Hung
Publikováno v:
Kaohsiung Journal of Medical Sciences, Vol 38, Iss 10, Pp 1001-1011 (2022)
Abstract Lung squamous cell carcinoma (LUSC) represents a minor proportion of nonsmall cell lung cancer (NSCLC) harboring a poor prognosis. Herein, retrospective medical record research was performed to investigate real‐world treatment patterns and
Externí odkaz:
https://doaj.org/article/db029e59fd1b48689719a60fac4223f8
Autor:
Ching-Chu Lo, Chung-Feng Huang, Pin-Nan Cheng, Kuo-Chih Tseng, Chi-Yi Chen, Hsing-Tao Kuo, Yi-Hsiang Huang, Chi-Ming Tai, Cheng-Yuan Peng, Ming-Jong Bair, Chien-Hung Chen, Ming-Lun Yeh, Chih-Lang Lin, Chun-Yen Lin, Pei-Lun Lee, Lee-Won Chong, Chao-Hung Hung, Te Sheng Chang, Jee-Fu Huang, Chi-Chieh Yang, Jui-Ting Hu, Chih-Wen Lin, Chun-Ting Chen, Chia-Chi Wang, Wei-Wen Su, Tsai-Yuan Hsieh, Chih-Lin Lin, Wei-Lun Tsai, Tzong-Hsi Lee, Guei-Ying Chen, Szu-Jen Wang, Chun-Chao Chang, Lein-Ray Mo, Sheng-Shun Yang, Wen-Chih Wu, Chia-Sheng Huang, Chou-Kwok Hsiung, Chien-Neng Kao, Pei-Chien Tsai, Chen-Hua Liu, Mei-Hsuan Lee, Chun-Jen Liu, Chia-Yen Dai, Wan-Long Chuang, Han-Chieh Lin, Jia-Horng Kao, Ming-Lung Yu
Publikováno v:
Journal of the Formosan Medical Association, Vol 121, Iss 8, Pp 1567-1578 (2022)
Background/purpose: The Taiwan Association for the Study of the Liver (TASL) HCV Registry (TACR) is a nationwide registry of chronic hepatitis C patients in Taiwan. This study evaluated antiviral effectiveness of ledipasvir (LDV)/sofosbuvir (SOF) in
Externí odkaz:
https://doaj.org/article/e3fc588ffb4644ea879b1c65ce5709a5
Autor:
Yu-Hsiang Chou, Ying-Chu Lin, Mei-Hsuan Lee, Yu-Ting Huang, Pei-Feng Liu, Chung-Lin Huang, Kai-Fang Hu
Publikováno v:
BMC Oral Health, Vol 22, Iss 1, Pp 1-7 (2022)
Abstract Background The outbreak of coronavirus disease 2019 (COVID-19) is rapidly changed medical habits, and dental clinics have been forced to adapt. This study explored the pandemic-induced changes in patient utilization of dental services to ass
Externí odkaz:
https://doaj.org/article/99fae272623b419fa139658ee7d1c2d7
Autor:
Mei-Hsuan Lee, Ping-Feng Wu, Tzu-I Chen, Chi Chan, Hsi-Hsun Lin, Yi-Hsiang Huang, Hsuan-Yu Chen, Yi-Tsung Lin, Chien-Jen Chen
Publikováno v:
JHEP Reports, Vol 5, Iss 3, Pp 100634- (2023)
Background & Aims: Tenofovir is recommended as part of the first-line antiretroviral therapy (ART) to treat people living with HIV (PLWH) with HBV coinfection. However, the effects of tenofovir-containing ART on hepatocellular carcinoma (HCC) risk am
Externí odkaz:
https://doaj.org/article/9c18d7db8667424387c4faef43740923